UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

Brain (London, England : 1878), 2009-11, Vol.132 (11), p.3152-3164

2009

Volltextzugriff (PDF)

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

British journal of clinical pharmacology, 2013-02, Vol.75 (2), p.323-333

2013

Volltextzugriff (PDF)

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

Brain (London, England : 1878), 2011-01, Vol.134 (Pt 1), p.119-136

2011

Volltextzugriff (PDF)

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease

Journal of neuroinflammation, 2018-05, Vol.15 (1), p.158-158, Article 158

2018

Volltextzugriff (PDF)

Proliferation of osteoblast precursor cells on the surface of TiO2 nanowires anodically grown on a β-type biomedical titanium alloy

Scientific reports, 2022-05, Vol.12 (1), p.7895-7895, Article 7895

2022

Volltextzugriff (PDF)

Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling

The Journal of biological chemistry, 2014-08, Vol.289 (32), p.21960-21972

2014

Volltextzugriff (PDF)

Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice

CNS & neurological disorders drug targets, 2017-01, Vol.16 (1), p.102-108

2017

Volltextzugriff (PDF)

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

Scientific reports, 2016-02, Vol.6 (1), p.21703-21703, Article 21703

2016

Volltextzugriff (PDF)

Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats

Frontiers in pharmacology, 2019-09, Vol.10, p.1131-1131

2019

Volltextzugriff (PDF)

aEEG and neurologic exam findings correlate with hypoxic-ischemic brain damage severity in a piglet survival model

Pediatric research, 2019-03, Vol.85 (4), p.539-545

2019

Volltextzugriff (PDF)

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor

Journal of neuroinflammation, 2018-01, Vol.15 (1), p.19-19, Article 19

2018

Volltextzugriff (PDF)

Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology

Journal of medicinal chemistry, 2016-03, Vol.59 (5), p.1840-1853

2016

Volltextzugriff (PDF)

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease

Journal of neuroscience research, 2011-09, Vol.89 (9), p.1509-1518

2011

Volltextzugriff (PDF)

Cannabidiol Reduces Brain Damage and Improves Functional Recovery After Acute Hypoxia-Ischemia in Newborn Pigs

Pediatric research, 2011-09, Vol.70 (3), p.272-277

2011

Volltextzugriff (PDF)

Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties

European journal of medicinal chemistry, 2016-04, Vol.112, p.66-80

2016

Volltextzugriff (PDF)

Hypoxic-ischemic brain damage induces distant inflammatory lung injury in newborn piglets

Pediatric research, 2016-03, Vol.79 (3), p.401-408

2016

Volltextzugriff (PDF)

Cannabinoids: Novel Medicines for the Treatment of Huntingtons Disease

Recent patents on CNS drug discovery, 2012-04, Vol.7 (1), p.41-48

2012

Volltextzugriff (PDF)

Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors

Neuropharmacology, 2013-08, Vol.71, p.282-291

2013

Volltextzugriff (PDF)

Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors

Neuropharmacology, 2013-08, Vol.71, p.282-291

2013

Volltextzugriff (PDF)

Cannabinoid CB 2 receptors in the mouse brain: relevance for Alzheimer's disease

Journal of neuroinflammation, 2018-05, Vol.15 (1), p.158

2018

Volltextzugriff (PDF)

Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer’s disease

Biochemical pharmacology, 2018-11, Vol.157, p.202-209

2018

Volltextzugriff (PDF)

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study

Synapse (New York, N.Y.), 2004-09, Vol.53 (4), p.208-213

2004

Volltextzugriff (PDF)

The cannabinoid agonist win55212 reduces brain damage in an In Vivo model of hypoxic-ischemic encephalopathy in newborn rats

Pediatric research, 2007-09, Vol.62 (3), p.255-260

2007

Volltextzugriff (PDF)

Proliferation of osteoblast precursor cells on the surface of TiO 2 nanowires anodically grown on a β-type biomedical titanium alloy

Scientific reports, 2022-05, Vol.12 (1), p.7895

2022

Volltextzugriff (PDF)

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-[gamma] and CB2 pathways

Scientific reports, 2016-02, Vol.6, p.21703

2016

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Englisch
(34)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(21)
Animals
(15)
Humans
(11)
Neurosciences
(10)
Neurosciences & Neurology
(10)
Male
(8)
Pharmacology & Pharmacy
(8)
Huntington's Disease
(6)
Hypoxia-Ischemia, Brain - Pathology
(6)
Mice
(6)
Neuroprotection
(6)
Receptor, Cannabinoid, Cb2 - Metabolism
(6)
Animals, Newborn
(5)
Biological And Medical Sciences
(5)
Cannabidiol
(5)
Cannabinoids
(5)
Disease Models, Animal
(5)
Inflammation
(5)
Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Pediatric Research
(4)
Scientific Reports
(4)
Journal Of Neuroinflammation
(3)
Brain
(2)
Glia
(2)
Neuropharmacology
(2)
Neurourology And Urodynamics
(2)
Recent Patents On Cns Drug Discovery
(2)
Synapse
(2)
Biochemical Pharmacology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease

Proliferation of osteoblast precursor cells on the surface of TiO2 nanowires anodically grown on a β-type biomedical titanium alloy

Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling

Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats

aEEG and neurologic exam findings correlate with hypoxic-ischemic brain damage severity in a piglet survival model

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor

Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease

Cannabidiol Reduces Brain Damage and Improves Functional Recovery After Acute Hypoxia-Ischemia in Newborn Pigs

Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties

Hypoxic-ischemic brain damage induces distant inflammatory lung injury in newborn piglets

Cannabinoids: Novel Medicines for the Treatment of Huntingtons Disease

Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors

Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors

Cannabinoid CB 2 receptors in the mouse brain: relevance for Alzheimer's disease

Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer’s disease

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study

The cannabinoid agonist win55212 reduces brain damage in an In Vivo model of hypoxic-ischemic encephalopathy in newborn rats

Proliferation of osteoblast precursor cells on the surface of TiO 2 nanowires anodically grown on a β-type biomedical titanium alloy

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-[gamma] and CB2 pathways

Suchergebnisse filtern